Home » Clinical Investigators Face Increased Scrutiny From US FDA
Clinical Investigators Face Increased Scrutiny From US FDA
September 15, 2009
As the U.S. Food and Drug Administration (FDA) increases its efforts to discipline clinical investigators, device sponsors should make sure they do not hire investigators who have been disqualified or debarred.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor